🇺🇸 FDA
Patent

US 9365557

Substituted pyrazin-2-amines as inhibitors of ATR kinase

granted A61PA61P35/00

Quick answer

US patent 9365557 (Substituted pyrazin-2-amines as inhibitors of ATR kinase) held by Vertex Pharmaceuticals Incorporated expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
54
CPC classes
A61P, A61P35/00